| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
phenotype | 0.210 | None | 1.000 | 2 | 0 | 2011 | 2013 | ||||||||
|
C-X3-C motif chemokine ligand 1 | 0.478 | 0.808 | 0.61 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2011 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2011 | 2017 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1992 | 2013 | ||||||||
|
argininosuccinate synthase 1 | 0.523 | 0.731 | 1.5E-09 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2000 | 2011 | ||||||||
|
ATP binding cassette subfamily C member 8 | 0.474 | 0.846 | 8.0E-24 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2007 | 2009 | ||||||||
|
complement C5a receptor 1 | 0.513 | 0.808 | 0.40 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1997 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2013 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1999 | 2020 | ||||||||
|
secreted protein acidic and cysteine rich | 0.445 | 0.846 | 0.89 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2006 | 2017 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1987 | 2018 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2004 | 2017 | ||||||||
|
phospholipase A2 group VII | 0.537 | 0.769 | 5.3E-22 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2000 | 2012 | ||||||||
|
von Willebrand factor | 0.408 | 0.885 | 3.2E-25 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 1989 | 2008 | ||||||||
|
integrin subunit alpha 2b | 0.493 | 0.692 | 1.5E-16 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2003 | 2005 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2006 | 2011 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
phenotype | 0.200 | None | 1.000 | 4 | 0 | 2010 | 2015 | ||||||||
|
activating transcription factor 2 | 0.551 | 0.808 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2011 | 2013 | ||||||||
|
phosphoenolpyruvate carboxykinase 1 | 0.608 | 0.538 | 8.7E-15 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2002 | 2009 | ||||||||
|
growth hormone receptor | 0.490 | 0.846 | 8.4E-05 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2002 | 2002 | ||||||||
|
thromboxane A2 receptor | 0.597 | 0.654 | 1.3E-04 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 1985 | 2005 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 | 0.555 | 0.654 | 0.72 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
prostaglandin E receptor 4 | 0.558 | 0.731 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 |